InvestSMART

SciDev Ltd (ASX: SDV) - Announcements

Current share price for SDV : $0.110 0.01 (8.33%)+

ASX company news and announcements for SciDev Ltd (SDV) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All SciDev Ltd (SDV) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than SciDev Ltd (SDV), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for SciDev Ltd (SDV)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$21 SciDev and Nuoer Cement and Expand Relationship 20 May 2019 9:10AM $0.081 $0.110 risen by 35.80%
$21 Optiflox Expands to Base and Precious Metals 2 May 2019 11:20AM $0.064 $0.110 risen by 71.88%
$21 Appointment of Lewis Utting as Managing Director & CEO 30 Apr 2019 4:18PM $0.065 $0.110 risen by 69.23%
$21 March 2019 Quarterly Report and Appendix 4C 24 Apr 2019 11:59AM $0.065 $0.110 risen by 69.23%
$21 Details of Company Address 15 Apr 2019 8:57AM $0.060 $0.110 risen by 83.33%
$21 Completion of Placement, Appendix 3B and Cleansing Statement 9 Apr 2019 9:42AM $0.060 $0.110 risen by 83.33%
$21 Tartana Transaction - Variation and Tartana Share Sale 8 Apr 2019 3:34PM $0.060 $0.110 risen by 83.33%
$21 Results of Meeting 28 Mar 2019 12:43PM $0.061 $0.110 risen by 80.33%
$21 Change of Director's Interest Notices 20 Mar 2019 6:30PM $0.061 $0.110 risen by 80.33%
$21 Resignation of Managing Director and Appendix 3Z 19 Mar 2019 7:18PM $0.061 $0.110 risen by 80.33%
$21 SciDev $1.25M Entitlements Issue 13 Mar 2019 9:52AM $0.070 $0.110 risen by 57.14%
$21 Extension of Peabody Optiflox and Chemical Supply Contract 5 Mar 2019 8:49AM $0.070 $0.110 risen by 57.14%
$21 SciDev 31 December 2018 Appendix 4D and Interim Report 28 Feb 2019 1:57PM $0.070 $0.110 risen by 57.14%
$21 Notice of General Meeting/Proxy Form 25 Feb 2019 1:49PM $0.073 $0.110 risen by 50.68%
$21 SciDev Entitlements Issue Offer Letter and Application Form 21 Feb 2019 9:37AM $0.070 $0.110 risen by 57.14%
$21 SciDev Letter to Eligible and Ineligible Shareholders 14 Feb 2019 11:26AM $0.090 $0.110 risen by 22.22%
$21 Reinstatement to Official Quotation 13 Feb 2019 9:58AM $0.072 $0.110 risen by 52.78%
$21 SciDev $2.5 Million Fund Raising to Accelerate Growth 13 Feb 2019 9:58AM $0.072 $0.110 risen by 52.78%
$21 SciDev Request for Continuation of Voluntary Suspension 11 Feb 2019 10:11AM $0.072 $0.110 risen by 52.78%
$21 SciDev Secures Exclusive Nuoer Product Rights and Placement 11 Feb 2019 10:10AM $0.072 $0.110 risen by 52.78%
$21 Suspension from Official Quotation 6 Feb 2019 9:44AM $0.072 $0.110 risen by 52.78%
$21 Trading Halt 4 Feb 2019 12:22PM $0.072 $0.110 risen by 52.78%
$21 Pause in Trading 4 Feb 2019 12:05PM $0.072 $0.110 risen by 52.78%
$21 Quarterly Activities Report and Appendix 4C 31 Jan 2019 5:40PM $0.050 $0.110 risen by 120%
$21 Purchase order received from Peabody Energy 30 Jan 2019 2:24PM $0.060 $0.110 risen by 83.33%

326 - 350 of 424 results

Page 14 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.